Dermatology/Skin - Other, Skin Cancer
Conditions
Brief summary
This feasibility study aims to evaluate the use of the BARCO NV digital dermatoscope (non-CE marked device) in the skin cancer clinic. All eligible patients attending the Dermatology outpatient skin cancer clinic will be invited to participate. Patients who consent to the study will undergo standard care which will include medical photography of skin lesion(s) and appropriate management as determined by the Consultant Dermatologist in clinic. In addition to standard care, patients will undergo photography of the same lesion(s) using the BARCO NV digital dermatoscope. There will be no other intervention and no additional hospital visits in relation to the study. Use of the device will not influence the clinical management of the patient. A detailed experience questionnaire will be administered to all clinicians using the BARCO device to explore their opinion on its ease of use and features. All standard macroscopic & dermoscopic images will be taken by OUH medical illustration department and stored on the 'Fotoweb' database (in keeping with current standard practice). Trained Dermatology Consultants, Dermatology Registrars, Research nurses or Medical Photographers, will take BARCO NV device images. A database of all BARCO images will be collected and stored on a dedicated NHS computer separate from the patient clinical record. Standard medical photography images will be stored on Fotoweb as per standard NHS clinical care. Data will be anonymised and collated and then sent securely to BARCO for further analyses to enable optimization of the BARCO device and for development of diagnostic algorithms in the future.
Interventions
DEVICEBarco NV Digital Dermatoscope device images
Images taken by Clinician in consultation OR in Dermatology department theatres OR images taken in medical photography suite - in the latter case, images can be taken by medical photographer or Research nurse or Dermatologist
DEVICEStandard medical photographs including dermoscopy images
Images taken by medical photographer as part of standard care in the medical photography suite.
OTHERClinic proforma completion
This is part of standard care and will be undertaken by the clinician who is responsible for the patient
Sponsors
Barco NV
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 years or above. * Patient presenting with any visible skin lesion for Dermatologist review on a body site amenable for optimal photographic imaging * Able and willing to comply with all study requirements. * Patient with a skin lesion that is clinically diagnosed by a Consultant Dermatologist as benign OR a suspicious skin lesion requiring excisional biopsy for histological diagnosis * Patient attending for a 'New' or 'Follow-up' consultation
Exclusion criteria
* Patients aged under 18 years old * Patients unable to provide informed consent * Skin lesions in an anatomical site which is not suitable for photography including genital lesion, hair-bearing site or subungual lesion * Maximum size of lesion 25 mm * Lesion is at a site where previous surgery was undertaken * Lesion on a mucosal site
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinician experience questionnaire results | 1 year | To assess the acceptability of the new dermoscope in the skin cancer clinic, questions about the usability of the device and about the image quality of the obtained dermoscopic pictures are included. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Collection of image database | 1 year | Anonymised database of clinicopathological and digital images of benign, malignant and equivocal skin lesions + Proportion of high quality images amenable to clinician evaluation |
| Safety of the device for the patient and the user: occurrence of adverse events | 1 year | Number of adverse events reported |
Countries
United Kingdom
Outcome results
None listed